Histologic similarities between lentigo maligna and dysplastic nevus: Importance of clinicopathologic distinction

Journal of Cutaneous Pathology

Volumn 32, Issue 6, 2005, Pages 405-412

  Farrahi, Farinaz ^a   Egbert, Barbara M ^a,b   Swetter, Susan M ^a,b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC ERROR; DYSPLASTIC NEVUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT LENTIGO; SKIN BIOPSY; SKIN DEFECT; SKIN PIGMENTATION; SUN EXPOSURE;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DIAGNOSIS, DIFFERENTIAL; DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SKIN NEOPLASMS;

EID: 20744448676     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0303-6987.2005.00355.x     Document Type: Article

References (46)

1. Clark WH Jr, Mihm MC Jr. Lentigo maligna and lentigo maligna melanoma. Am J Pathol 1969; 55: 39.
2. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995; 33: 923.
3. Dubow BE, Ackerman AB. Ideas in pathology; malignant melanoma in situ: the evolution of a concept. Mod Pathol 1990; 3: 734.
4. Barnhill RL, Mihm MJ. The histopathology of cutaneous malignant melanoma. Semin Diagn Pathol 1993; 10: 47.
5. Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol 1987; 116: 303.
6. Jackson R, Williamson GS, Beattie WG. Lentigo maligna and lentigo maligna melanoma. Can Med Assoc J 1966; 95: 846.
7. Cohen LM. What's new in lentigo maligna. Adv Dermatol 1999; 15: 203.
8. Swetter SM, Jung S, Harvell J, Egbert B. Increased proportion of lentigo maligna and lentigo maligna melanoma subtypes in the Veterans Affairs Palo Alto Health Care System and Stanford University Medical Center. J Invest Dermatol 2002; 119: 245 [abstract].
9. Pennys NS. Microinvasive lentigo maligna melanoma. J Am Acad Dermatol 1987; 17: 675.
10. Cohen LM. The starburst giant cell is useful for distinguishing lentigo maligna from photodamaged skin. J Am Acad Dermatol 1996; 35: 962.
11. Kossard S. Atypical lentiginous junctional naevi of the elderly and melanoma. Australas J Dermatol 2002; 45: 95.
12. Kim JC, Murphy GF. Dysplastic melanocytic nevi and prognostically indeterminate nevomelanomatoid proliferations. Clin Lab Med 2000; 20: 691.
13. Blessing K. Benign atypical naevi: diagnostic difficulties and continued controversy. Histopathology 1999; 34: 189.
14. Weedon D, Strutton G. Skin pathology. London: Churchill Livingstone, 2002; 1819.
15. Clark WH Jr, From L, Bernardino EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969; 29: 705.
16. Arrington JH III, Reed RJ, Ichinose H, Krementz ET. Plantar lentiginous melanoma: a distinctive variant of human cutaneous malignant melanoma. Am J Surg Pathol 1977; 1: 131.
17. Coleman WP III, Loria PR, Reed RJ, Krementz ET. Acral lentiginous melanoma. Arch Dermatol 1980; 116: 773.
18. Ackerman AB. Malignant melanoma: a unifying concept. Hum Pathol 1980; 11: 591.
19. Ackerman AB, David KM. A unifying concept of malignant melanoma: biologic aspects. 1986; 17: 438.
20. Ackerman AB. Mythology and numerology in the sphere of melanoma. Cancer 2000; 88: 491.
21. Heenan PJ, Matz LR, Blackwell JB. et al. Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia. Histopathology 1984; 8: 717.
22. Krieger N, Hiatt RA, Sagebiel RW, Clark WH Jr, Mihm MC Jr. Inter-observer variability among pathologists' evaluation of malignant melanoma; effects upon an analytic study. J Clin Epidemiol 1994; 47: 897.
23. Corona R, Mele A, Amini M, et al. Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol 1996; 14: 1218.
24. Weyers W, Euler M, Diaz-Cascajo C, Schill W-B, Bonczkowitz M. Classification of cutaneous malignant melanoma: a reassessment of histopathologic criteria for the distinction of different types. Cancer 1999; 86: 288.
25. Flotte TJ, Mihm MC. Lentigo maligna and malignant melanoma in situ, lentigo maligna type. Hum Pathol 1999; 30: 533.
26. Tannous ZS, Lerner LH, Duncan LM, Mihm MC, Flotte TJ. Progression to invasive melanoma from malignant melanoma in situ, lentigo maligna type. Hum Pathol 2000; 31: 705.
27. Clark WH Jr, Ainsworth AM, Bernardino EA, Yan CH, Mihm CM Jr, Reed RJ. The developmental biology of primary human malignant melanomas. Semin Oncol 1975; 2: 83.
28. Sagebiel RW. Unusual variants of melanoma: fact or fiction? Semin Oncol 1996; 23: 703.
29. McGovern VJ, Shaw HM, Milton GW, Farago GA. Is malignant melanoma arising in Hutchinson's melanotic freckle a separate disease entity? Histopathology 1980; 4: 235.
30. Elwood JM, Gallagher RP, Worth AJ, Wood WS, Pearson JC. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada melanoma study. J Natl Cancer Inst 1987; 78: 37.
31. Holman CDJ, Armstrong BK, Heenan PJ. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma. J Natl Cancer Inst 1983; 71: 651.
32. Holman CDJ, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73: 75.
33. Urist MM, Balch CM, Soong SJ, Milton GW, Shaw HM, McGovern VJ, Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment Ann Surg 1984; 200: 769.
34. O'Brien CJ, Coates AS, Peterson-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg 1991; 162: 310.
35. Cox NH, Aitchison TC, Sirel JM, MacKie RM, Scottish Melanoma Group. Comparison between lentigo malignan melanoma and other histogenetic types of malignant melanoma of the head and neck. Br J Cancer 1996; 73: 940.
36. Koh HK, Michalik E. Sober AJ, et al. Lentigo maligna melanoma has not better prognosis than other types of melanoma. J Clin Oncol 1984; 2: 994.
37. Langford FPJ, Fisher SR, Molter DW, Seigler HF. Lentigo maligna melanoma of the head and neck. Laryngoscope 1993; 103: 520.
38. Swetter SM. Dermatological perspectives of malignant melanoma. Surg Clin N Am 2003; 83: 77.
39. Langley RG, Fitzpatrick TB, Sober AJ. Clinical characteristics. In: Balch CM, Houghton AN, Sober AJ, Soong S-j, eds. Cutaneous melanoma, 3rd ed. St Louis: Quality Medical Publishing, 1998; 81.
40. Kroumpouzos G, Frank WE, Albertini JG. et al. Lentigo maligna with spread onto oral mucosa. Arch Dermatol 2002; 138: 1216.
41. Clark WH Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions 'the B-K mole syndrome.' Arch Dermatol 1978; 114: 732.
42. De Wit PE, van't Hof-Grootenboer B, Ruiter DJ, et al. Validity of the histopathological criteria used for diagnosing dysplastic naevi. An interobserver study by the pathology subgroup of the EORTC Malignant Melanoma Cooperative Group. Eur J Cancer 1993; 29: 831.
43. Piepkorn MW, Barnhiss RL, Cannon-Albright LA, et al. A multiobserver, population-based analysis of histologic dysplasia in melanocytic new. J Am Acad Dermatol 1994; 30: 707.
44. Poso L, Naase M, Cerio R, Blanes A, Diaz-Cano SJ. Critical analysis of histologic criteria for grading atypical (dysplastic) melanocytic nevi. Am J Clin Pathol 2001; 115: 194.
45. Brochez L, Verhaeghe E, Grosshans E, et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 2002; 196: 459.
46. Cook MG, Clarke TJ, Humphresy S, et al. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel. Histopathology 1996; 28: 497.